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Original Article

Electromagnetic navigation transthoracic needle aspiration for
the diagnosis of pulmonary nodules: a safety and feasibility pilot
study
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Background: Pulmonary nodules remain a diagnostic challenge for physicians. Minimally invasive
biopsy methods include bronchoscopy and CT guided transthoracic needle aspiration (TTNA). A novel
electromagnetic guidance transthoracic needle aspiration (ETTNA) procedure which can be combined
with navigational bronchoscopy (NB) and endobronchial ultrasound (EBUS) in a single setting has become
available.
Methods: A prospective pilot study examining the safety, feasibility and diagnostic yield of ETTNA in a
single procedural setting. All patients enrolled underwent EBUS for lung cancer staging followed by NB
and ETTNA. Feasibility of performing ETTNA and a safety assessment by recording procedural related
complications including pneumothorax or bleeding was performed. Diagnostic yield of ETTNA defined by
a definitive pathologic tissue diagnosis was recorded. An additional diagnostic yield analysis was performed
using a cohort analysis of combined interventions (EBUS + NB + ETTNA). All non-diagnostic biopsies were
either followed with radiographic imaging or a surgical biopsy was performed.
Results: Twenty-four subjects were enrolled. ETTNA was feasible in 96% of cases. No bleeding events
occurred. There were five pneumothoraces (21%) of which only two (8%) subjects required drainage. The
diagnostic yield for ETTNA alone was 83% and increased to 87% (P=0.0016) when ETTNA was combined
with NB. When ETTNA and NB were performed with EBUS for complete staging, the diagnostic yield
increased further to 92% (P=0.0001).
Conclusions: This is the first human pilot study demonstrating an acceptable safety and feasibility profile
with a novel ETTNA system. Further studies are needed to investigate the increased diagnostic yield from
this pilot study.
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Introduction
Results of the National Lung Screening Trial (NLST) found
a 20% risk in lung cancer related deaths in patients screened
annually for 3 years with low dose CT. Currently, over
8 million Americans meet criteria for lung cancer screening (1)
with more than 10 million chest CT scans performed
annually in the United States (2,3). This number is likely
to escalate in part due to the results of the NLST and
subsequent Medicare coverage of lung cancer screening (4,5).
However, the management of solitary pulmonary nodules
(SPN) remains a diagnostic challenge. The majority of
nodules will be benign, but the opportunity to diagnose
an early and potentially curable lung cancer is critical (6).
The benefit of an early diagnosis also needs to be weighed
against the risk of procedural complications.
The three most common methods to diagnose a SPN
are bronchoscopy, transthoracic needle aspiration (TTNA),
and surgical biopsy (7). Despite new technologies, the
diagnostic yield for bronchoscopy remains as low as 33% (8).
Developing a systematic approach that combines staging
of disease in combination with a high diagnostic yield in
the periphery, without increased complications are needed.
Recently, a novel diagnostic tool has been developed
allowing for physicians to perform electromagnetic
guidance transthoracic needle aspiration (ETTNA).
The technology incorporates a unique electromagnetic
guidance system allowing clinicians to track SPN and
target them for ETTNA without utilizing real time CT
in the operating room or bronchoscopy suite. Providing
this capability allows the pulmonologist to perform
initial lymph node staging with endobronchial ultrasound
(EBUS) in the same procedural setting. This approach
may provide a much needed intervention allowing
physicians to utilize a multimodality approach in a single
procedural setting to optimize diagnostic yield and limit
complications.
We report the safety, feasibility and diagnostic yield
performing a complete staging and diagnostic evaluation
in patient with a SPN utilizing a novel thoracic navigation
system which allows a combination of minimally invasive
biopsies [EBUS, navigational bronchoscopy (NB), ETTNA]
in a single procedural session.
Methods
This was a prospective single arm pilot study examining the
safety, feasibility and diagnostic yield of ETTNA, NB and
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EBUS in a single procedural setting. Institutional Review
Board approval was obtained at the Johns Hopkins Hospital
(NA00086035) and the trial was registered on clinicaltrials.
gov (NCT02109458). Primary outcomes were feasibility
of procedural performance and adverse events from
ETTNA including pneumothorax, chest tube requirement,
respiratory distress, and bleeding. The secondary outcome
was diagnostic yield.
Patients were enrolled after informed consent from
November 2013 until August 2014. Inclusion criteria
included; age >18 years, undiagnosed SPN (≥10 mm
and ≤30 mm surrounded by lung parenchyma) that were
accessible by an anterior or lateral chest percutaneous
approach with a clinical indication to undergo bronchoscopy
for diagnosis of a SPN. Subjects were excluded if they had
positron emission tomography (PET) positive mediastinal
lymphadenopathy and/or mediastinal lymphadenopathy
≥10 mm on CT imaging, clinical contradictions to undergo
standard flexible bronchoscopy, inability to provide
informed consent or age ≤18 years of age.
On the day of the procedure, all patients underwent
a chest CT scan to create a virtual airway map (Veran
Medical, St Louis, MO, USA) with 0.5 mm intervals and
0.67–0.75 mm thickness after placement of a navigational
tracking pad (vPAD2, Veran Medical) on the patients
anterior chest (Figure 1). The target nodule was identified
and a virtual bronchoscopic planning route to the SPN was
created (Figure 2). The chest wall entry site for ETTNA
was selected by the performing bronchoscopist to avoid
organ or vascular injury and a confirmed navigational
pathway to the SPN (target crosshairs within the target
lesion) was identified (Figure 3).
All patients were placed under deep sedation by a
board certified anesthesiologist with a laryngeal mask
airway in place. Patients were observed under standard
bronchoscopy monitoring protocols. Procedures were
performed by an Interventional Pulmonologist at the
Johns Hopkins Hospital (LY, DFK, and HL). A convex
EBUS (Olympus BF-UC180F) was performed for full
lymph node staging. This was followed by NB (SPiNView®
Thoracic Navigation System, Veran Medical) using an
electromagnetic tip tracked biopsy instrument (1.8 mm
OD Serrated Cup Always-On Tip Tracked Forceps, Veran
Medical) via a thin bronchoscope with a 4-mm outer
diameter (Olympus BF-MP160F). The biopsy instrument
was navigated to the SPN if the SPN was localized by
NB [target crosshairs within the target lesion with the tip
tracked instrument, a transbronchial forceps (TBBX) and/or
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Targeting view
plan RLL

Distance to target
9.9 mm

Figure 1 Tracking pad placed on the anterior chest that acts as a
stationary reference point on the patient obtained from the CT
dataset. It remains in the same spot during the procedure to enable
automatic registration when using electromagnetic navigation and
maintains registration regardless of patient movement.

Targeting view
90 plan RLL

Figure 3 Electromagnetic guidance TTNA planning of CT scan
with multiple views of a peripheral right lower lobe lesion (pink
with red cross hair target) 9.9 mm from the chest wall. The needle
path is represented by the yellow line that is positioned over the
Figure 2 Computer software generated map of airway anatomy with

superior surface of the rib and free of any vascular structures.

guidance (green) to the target lesion in the left upper lobe (purple).

TTNA, transthoracic needle aspiration.

TBNA with brushings and bronchoalveolar lavage (BAL)]
were performed (Figure 4). If onsite cytology evaluation of
the peripheral sample yielded a positive diagnosis, additional
samples were collected for mutational analysis. If NB did
not yield a confirmatory onsite diagnosis, the bronchoscope
was removed and ETTNA (Veran Medical, SpinPerc)
was attempted under continued deep sedation. Under
sterile conditions, the biopsy area was prepped and draped.
One percent lidocaine was injected subcutaneously followed
by percutaneous placement of an electromagnetic tip
tracked biopsy needle introducer (19 gauges × 105 mm)
under navigational guidance (Figure 5). The SPN was
localized and a 20-gauge coaxial core biopsy device

(SuperCore Argon Medical) device was used. The biopsy
device was rotated 90 degrees after each biopsy and a
minimum of four samples were obtained. After the ETTNA
samples were obtained, the needle introducer was removed
and a simple bandage was placed. Sedation was then weaned
and the patient was transported to the postoperative care
unit for standard monitoring.
All subjects had a post procedural chest radiograph
within two hours of the procedure. If a pneumothorax was
present, chest tube insertion criteria was based on the British
Thoracic Society guidelines and the patient was admitted
for chest tube management (9). If chest tube placement was
not needed, a four hour follow up chest radiograph was
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Figure 4 CT with multiple views (top) and computer software generated map (bottom) of airway anatomy with guidance (white line) to the
target lesion in the right upper lobe (purple). The blue cylinder represents the trackable biopsy instrument used for parenchymal sampling
under navigation guidance.

A

B

C

Figure 5 Electromagnetically guided TTNA needle placement. Needle insertion on the chest wall (A) with superior/inferior (B) and medial/
lateral (C) electromagnetic guidance. TTNA, transthoracic needle aspiration.
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Enrollment

Assessed eligibility (n=594)
Excluded (n=559)
• Not meeting inclusion criteria (n=548)
• Declined to participate (n=11)
Enrolled (n=24)

Allocation

Allocated to intervention (n=24)
• Received allocated intervention (n=24)
• Did not receive allocated intervention (give reasons) (n=0)

Follow-up

Lost to follow-up (geive reasons) (n=0)
Discontinued intervention (give reasons) (n=0)

Analysis

Analysed (n=24)
• Excluded from analysis (give reasons) (n=0)

Figure 6 Patient flow diagram.

performed and if the pneumothorax was stable or decreasing
in size the patient was discharged to home with short term
interval follow up to confirm complete resolution.
Additional data collected included patient demographics,
nodule size (longest axis), nodule location, presence of
air bronchus sign, distance from the pleural surface to
the edge of the nodule in its shortest path, complications
(pneumothorax, respiratory distress, hemoptysis, bleeding
graded), diagnostic results, and time for each component
of the procedure (EBUS, NB, ETTNA). Bleeding
complications during the procedure were recorded using a
modified bleeding scale (Grade 0= none, 1= suction, 2= iced
saline, 3= bronchial blocker, 4= surgical intervention).
All non-diagnostic biopsies underwent short interval
follow up CT imaging which unless the CT revealed a
decrease in size or complete resolution of the nodule within
six months; all patients underwent a video assisted wedge
resection for a definitive diagnosis by a board certified
thoracic surgeon. Nodules with a non-malignant but non
disease specific definitive pathologic diagnosis (i.e., fibrosis)
after the procedure were followed for at least twelve months
with surveillance CT to ensure stability with plans for a video
assisted wedge resection if there was any observed growth.
Statistical comparisons were made using chi-square
analysis where applicable. Continuous variables are described
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using means with standard deviations (SD) along with
range and/or 95% confidence intervals based on normal
theory. Dichotomous variables are summarized in simple
proportions along with exact binomial 95% confidence
intervals. Statistical comparisons of continuous variables were
done using ANOVA, while those comparing proportions
were done using the Fisher’s exact test. A P value of less than
0.05 indicated statistical significance. The statistical power
analysis (80% power and a one-sided alpha of 0.05) was based
on the a priori hypothesis that the combined diagnostic yield
of ETTNA and NB would result in a diagnostic yield of 85%
when compared to historical controls of NB alone. For the
comparative cohort we assumed a bronchoscopic diagnostic
yield of 61% utilizing historical control data for SPN of
this size (10). The sample size for these parameters was
24 patients. All statistical analysis was performed using
STATA software (version 13.1).
Results
A total of 594 patients (all patients undergoing any
bronchoscopy during the enrollment period) were assessed
for eligibility of which 35 met inclusion criteria during the
study period. Eleven patients declined consent (Figure 6).
Twenty-four subjects were recruited into the study (Table 1).
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Table 1 Characteristics of patients and lung nodules

Table 2 Lung nodule characteristics

Characteristics

Characteristics

All patients

Size (mm) mean [range]

20.3 [12-29]

All patients

Patients
Age (years) mean [range]

24
68 [52-85]

Gender [n, %]
Male
Female

Left lower lobe

2 [8]

9 [38]

Left upper lobe

10 [42]

15 [63]

Right lower lobe

1 [4]

Right middle lobe

2 [8]

Right upper lobe

8 [33]

Lingual

1 [4]

Smoking history
Pack-years mean [range]

31 [0-210]

COPD [n, %]
Diagnosis
Yes

Location [n, %]

Distance from pleura (mm) mean (range)
9 [38]

Gold score

12.6 (1.6-29.5)

Radiographic characteristics [n, %]
Ground glass opacity

5 [21]

1

5 [56]

Solid

19 [79]

2

3 [33]

Pet positive

21 [88]

3

0 [0]

Air bronchus present

11 [46]

4

1 [11]

COPD, chronic obstructive pulmonary disease.

Figure 7 CT chest revealing a revealing a left upper lobe nodule
distance 17.7 mm from the pleural surface to the edge of the
nodule in its shortest path distance (yellow line).

Twenty-four EBUS and NB and twenty-three ETTNA
cases were performed. In one subject an ETTNA was not
performed due to an anatomic limitation of an intercostal
rib interfering with the needle entry angle for ETTNA.
The mean SPN size was 20.3 mm (range, 12–29 mm) and
mean distance from the pleural surface to the edge of the
nodule in its shortest path distance was 12.6 mm (range,
1.6–29.5 mm) (Figure 7). Anatomic lobar location of the
nodule, measurements and radiographic specifics are
presented in Table 2.
No bleeding, hemoptysis, or respiratory events were

© Journal of Thoracic Disease. All rights reserved.

encountered. There were five (5/24, 21%) pneumothoraces
of which only two (2/24, 8%) subjects required chest
tube placement. None of the chest tube placements were
emergent. In the five cases with a pneumothorax, 4/5 (80%)
had a diagnosis from the procedure. All four of these cases
were diagnostic from the ETTNA sample alone. All five
samples from patients who experienced a pneumothorax
yielded lung tissue on pathologic analysis.
Total procedural time as defined by the time the EBUS
bronchoscope was inserted into the oropharynx until the
time the ETTNA needle was removed was 72.5 minutes.
Total EBUS procedural time from insertion of the EBUS
scope to removal of the EBUS scope was 20.5 minutes. Total
NB time as defined by the time from initial insertion of the
flexible bronchoscope into the oropharynx until removal of
the scope at the conclusion of the NB phase of the procedure
was 22.9 minutes. Total ETTNA time as defined by the start
of sterile field preparation prior to initial needle placement
until needle removal was 18.3 minutes.
The diagnostic yield for ETTNA alone was 83% alone.
The combined diagnostic yield of ETTNA and NB was 87%
(P=0.0016; exact 95% CI: 65%, 97%). The diagnostic yield
increased further when combining EBUS, NB and ETTNA
in a single procedure to 92% (P=0.0001). NB was diagnostic
in only 33% of all cases, but had a diagnostic yield of 73%
when an air bronchus sign was present on CT scan consistent
with prior navigational data for SPN bronchoscopic targets
within the inclusion criteria (11).
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Table 3 Histopathologic diagnosis of lung nodules
Diagnosis

All patients

Histopathology [n, %]
Benign diagnosis
Infection/inflammation

6 [25]

Granuloma

1 [4]

Fibrosis

3 [13]

Cancer diagnosis
Adenocarcinoma

7 [29]

Squamous cell

3 [13]

Sarcomatoid carcinoma

1 [4]

Hurthle cell

1 [4]

Carcinoid (typical)

1 [4]

Melanoma

1 [4]

ETTNA was the only biopsy method that was diagnostic
in nine subjects, and NB was the only diagnostic biopsy
method in one subject. EBUS was diagnostic in five cases
with four EBUS cases revealing adenocarcinoma (N3=1,
N1=3) and one case revealing granuloma. Of the four
EBUS malignant cases, three were also diagnostic by NB
and/or ETTNA. 13/24 (54%) of the patients enrolled had
a final malignant diagnosis. One hundred percent of the
patients had a definitive final diagnosis at the conclusion of
this study (Table 3).
Three cases of inflammatory changes seen on biopsy were
followed with short term CT surveillance which all revealed
a decrease in size or resolution at which point the result was
labeled as a true positive finding. Four subjects with a nonmalignant diagnosis including non-necrotizing granulomas
(sarcoidosis) and fibrosis were followed radiographically for
12 months with nodule stability in all cases.
Discussion
CT guided TTNA is the proven minimally invasive standard
for SPN diagnostics and has a higher diagnostic yield than
bronchoscopy (8,12-14). However, the rate of TTNA
complications is higher with a pneumothorax rate as high
as 43% vs. ≤4% with bronchoscopy (15). Although TTNA
may provide access to the primary lesion, it lacks the ability
to provide staging information requiring some patients to
undergo an additional separate procedure prior to treatment
(i.e., EBUS or mediastinoscopy). A minimally invasive
alternative to TTNA is desired for diagnosing SPN, but the
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yields of these technologies were historically lacking.
The results of our pilot study using a novel electromagnetic
guidance system to perform ETTNA resulted in a 96%
feasibility rate of bronchoscopists performing ETTNA with an
acceptable safety profile. Although TTNA may be a relatively
underutilized procedure for pulmonologists, our pneumothorax
rates were comparable to the NLST pneumothorax data in
procedures performed by interventional radiologists with
comparable chest tube placement rates. The additional time
to perform the ETTNA was shorter than either EBUS
or NB and more importantly, the additional procedure
time was not associated with any anesthesia related
complications. Given that ETTNA sampling is not based
on real time image guidance but on a computer generated
model, there was potential concern that a pneumothorax
would affect overall diagnostic yield. However, despite the
presence of a pneumothorax, a definitive diagnosis was still
obtained in 4/5 (80%) of subjects with a pneumothorax.
The combination of performing ETTNA, NB and
EBUS in a single procedural setting resulted in a 92%
overall diagnostic yield. Given the pilot design of this study,
the overall diagnostic yield data needs larger clinical trials
to confirm, however the pilot data does support the safety
and feasibility of pulmonologists to perform this procedure
in a single setting. There may in fact be additional safety
benefits of this combined modality by limiting separate
procedures (bronchoscopy and CT guided TTNA) and the
independent variable anesthesia risks associated with each
procedural encounter. The potential advantage of further
increases in yield and decreases in pneumothorax rates with
the use of rapid on-site cytology (ROSE) in combination
with EBUS + NB + ETTNA is promising. Performing
procedures in a stepwise fashion with ROSE and EBUSTBNA first followed by NB followed by ETTNA if needed
may further reduce complications. A stepwise algorithm
with ROSE may allow for a diagnostic procedure with an
even lower pneumothorax risk by performing transbronchial
biopsy or TBNA and/or TTNA in only those cases that are
needed. In this new era of health care reform and patient
centered safety metrics, another clear advantage may be a
single health care encounter which may allow for a patient
to obtain all minimally invasive biopsies and diagnosis in
one single setting. This approach could also help limit the
need for invasive surgical biopsies until all other minimally
invasive technics have not confirmed a diagnosis.
The diagnostic yield of ETTNA and NB was
87% (P=0.0016) and results in a potential clinically
significant and meaningful improved outcome over prior
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bronchoscopic yield. The diagnostic yield for ETTNA
alone was 82%, which was significantly better than NB but
lower than some prior reports of TTNA by radiologists. A
potential explanation may be that our nodule characteristics
were heterogeneous with a mix of solid/semi-solid nodules
(20.8% semi-solid). Reports of TTNA biopsy for semisolid
nodules have a markedly lower sensitivity than solid
nodules (51–84%) (16-18). Evidence that may also suggest
procedural differences between subspecialists do not
account for differences in yield or complications as shown
by the fact that there were no run in procedures performed
prior to study recruitment and no difference in complication
rates between providers or sequential procedures.
There are several limitations to this study. Although
powered for diagnostic yield, this pilot study was
performed at a single high volume center with experienced
bronchoscopists with significant NB experience and thus
the generalizability of the yield results of this study warrant
further investigation with larger clinical trials. However, the
NB yield overall was comparable to previously published data
suggesting the bronchoscopic approach is generalizable to a
wide array of pulmonary practices (19). In addition, none of
the investigators had any significant prior experience with
this NB system or any prior experience with ETTNA. In this
study the overall NB was only 33%. Although this is within
the reported yield based on historical data, the fact that only
SPN with a mean size of 20.3 mm were included reflect the
true diagnostic challenges that pulmonologists are faced
with in the setting of SPN (20). It is also established that the
diagnostic yield markedly decreases without the air bronchus
sign as again reflected in our study and favors using NB
when an air bronchus sign is present (21). This highlights the
limitations of bronchoscopic biopsy methods due to airway
confinement and stresses the importance of novel combined
minimally invasive methods including ETTNA. To further
validate the yield results and provide an algorithmic approach
to EBUS, NB and ETTNA, prospective multicentered
studies are needed.
Conclusions
This is the first human pilot study demonstrating an
acceptable safety and feasibility profile with a novel thoracic
navigation system. Multicentered prospective trials to
utilize a step-wise algorithmic approach to nodule sampling
are needed to confirm these findings.
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